Will Neuralink’s valuation hit __ by December 31?

Traders currently price "↑$45B" at 100% for "Will Neuralink’s valuation hit __ by December 31?". Over the past 24 hours that probability moved up 4.0 points. Full distribution: ↑$45B 100%, ↑$42.5B 100%, ↑$40B 100%, ↑$50B 77%. The market has traded $80K in total volume and resolves Jan 1, 2027. Neuralink’s last primary funding round closed in mid-2025 at a roughly $9 billion post-money valuation following a $650 million Series E, more than doubling the prior mark. Secondary-market transactions have since driven implied valuations sharply higher, with recent trades and bids reported between $29 billion and $42 billion as of July 2026, reflecting strong investor appetite for the brain-computer interface platform despite the company remaining pre-revenue. Key supporting developments include expanded human trials across multiple countries, two FDA Breakthrough Device Designations for speech and vision restoration, and announcements of a shift toward higher-volume manufacturing in 2026. No IPO timeline has been disclosed, leaving valuation movements dependent on further clinical milestones, potential follow-on primary rounds, and broader private-market sentiment toward Elon Musk-linked companies through year-end.

Odds sourced live from Polymarket, refreshed through the day. Prediction-market participation carries risk and may be restricted in your jurisdiction. Informational only — not investment advice.